Inclusion Criteria

DISEASE CHARACTERISTICS: Histologically proven low grade lymphoma in the following
settings: Consolidation of newly diagnosed stage IV high-risk patients after 6-9 months of
intensive conventional dose chemotherapy involving doxorubicin High risk is defined as >=5
cm adenopathy and >=2 extranodal sites at diagnosis, or males with >=5 cm adenopathy and >
20% marrow infiltrate at diagnosis) Failure to achieve CR within 6 months in newly
diagnosed patients with intensive doxorubicin treatment Relapse patients who are sensitive
to doxorubicin or ESHAP chemotherapies Patients with resistant chemotherapy failure
(allogeneic BMT only) Patients with HLA-identical sibling donors are eligible for
allogeneic bone marrow transplantation; other patients are eligible for autologous marrow
transplantation Bone marrow must be in complete or near complete remission (< 15 %
malignant cells) in autologous transplant patients

PATIENT CHARACTERISTICS: Age: 15 to 60 years Performance Status: Zubrod 0-2 Hematopoietic:
Not specified Hepatic: Bilirubin no greater than 1.5 mg/dL Renal: Creatinine no greater
than 2.0 mg/dL Cardiovascular: Cardiac ejection fraction at least 50% Pulmonary: DLCO at
least 50% Other: No concomitant severe medical illnesses No psychosis

PRIOR CONCURRENT THERAPY: Biologic therapy: Not specified Chemotherapy: Prior chemotherapy
allowed Endocrine therapy: Not specified Radiotherapy: No prior extensive radiotherapy
Surgery: Not specified